Superior Predictive Value of D-Dimer to the Padua Prediction Score for Venous Thromboembolism in Inpatients with AECOPD: A Multicenter Cohort Study

References

• Bosson JL, Barro C, Satger B., et al. Quantitative high D-dimer value is predictive of pulmonary embolism occurrence independently of clinical score in a well-defined low risk factor population. J Thromb Haemost. 2005;3(1):93–99. doi:10.1111/j.1538-7836.2004.01045.x
   PubMed Web of Science ®Google Scholar
• Suissa S, Dell’Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax. 2012;67:957–963. doi:10.1136/thoraxjnl-2011-201518
   PubMed Web of Science ®Google Scholar
• Aleva FE, Voets L, Simons SO, et al. Prevalence and localization of pulmonary embolism in unexplained acute exacerbations of COPD: a systematic review and meta-analysis. Chest. 2017;151(3):544–554. doi:10.1016/j.chest.2016.07.034
   PubMed Web of Science ®Google Scholar
• Ko FW, Chan KP, Hui DS, et al. Acute exacerbation of COPD. Respirology. 2016;21:1152–1165. doi:10.1111/resp.12780
   PubMed Web of Science ®Google Scholar
• Rizkallah J, Man SFP, Sin DD. Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis. Chest. 2009;135:786–793. doi:10.1378/chest.08-1516
   PubMed Web of Science ®Google Scholar
• Pang H, Wang L, Liu J, et al. The prevalence and risk factors of venous thromboembolism in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease. Clin Respir J. 2018;12:2573–2580. doi:10.1111/crj.12959
   PubMed Web of Science ®Google Scholar
• Kubota Y, London SJ, Cushman M, et al. Lung function, respiratory symptoms and venous thromboembolism risk: the Atherosclerosis Risk in Communities Study. J Thromb Haemost. 2016;14:2394–2401. doi:10.1111/jth.13525
   PubMed Web of Science ®Google Scholar
• Morgan AD, Herrett E, De Stavola BL, et al. COPD disease severity and the risk of venous thromboembolic events: a matched case-control study. Int J Chron Obstruct Pulmon Dis. 2016;11:899–908. doi:10.2147/COPD.S100533
   PubMed Web of Science ®Google Scholar
• Børvik T, Brækkan SK, Enga K, et al. COPD and risk of venous thromboembolism and mortality in a general population. Eur Respir J. 2016;47(2):473–481. doi:10.1183/13993003.00402-2015
   PubMed Web of Science ®Google Scholar
• Dong F, Huang K, Ren X, et al. Factors associated with inpatient length of stay among hospitalised patients with chronic obstructive pulmonary disease, China, 2016-2017: a retrospective study. BMJ Open. 2021;11:e040560. doi:10.1136/bmjopen-2020-040560
   PubMed Web of Science ®Google Scholar
• Dentali F, Douketis JD, Gianni M, et al. Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med. 2007;146:278–288. doi:10.7326/0003-4819-146-4-200702200-00007
   PubMed Web of Science ®Google Scholar
• Liu X, Liu C, Chen X, et al. Comparison between Caprini and Padua risk assessment models for hospitalized medical patients at risk for venous thromboembolism: a retrospective study. Interact Cardiovasc Thorac Surg. 2016;23:538–543. doi:10.1093/icvts/ivw158
   PubMed Web of Science ®Google Scholar
• Fraisse F, Holzapfel L, Couland JM, et al. Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. The Association of Non-University Affiliated Intensive Care Specialist Physicians of France. Am J Respir Crit Care Med. 2000;161:1109–1114. doi:10.1164/ajrccm.161.4.9807025
   PubMed Web of Science ®Google Scholar
• Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost. 2010;8(11):2450–2457. doi:10.1111/j.1538-7836.2010.04044.x
   PubMed Web of Science ®Google Scholar
• Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis. Chest. 2012;141:e195S–e226S. doi:10.1378/chest.11-2296
   PubMed Web of Science ®Google Scholar
• Johnson ED, Schell JC, Rodgers GM. The D-dimer assay. Am J Hematol. 2019;94:833–839. doi:10.1002/ajh.25482
   PubMed Web of Science ®Google Scholar
• Bruinstroop E, Klok FA. Elevated D-dimer levels predict recurrence in patients with idiopathic venous thromboembolism: a meta-analysis. J Thromb Haemost. 2009;7:611–618. doi:10.1111/j.1538-7836.2009.03293.x
   PubMed Web of Science ®Google Scholar
• Al-Samkari H, Karp Leaf RS, Dzik WH, et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020;136:489–500. doi:10.1182/blood.2020006520
   PubMed Web of Science ®Google Scholar
• Mebazaa A, Spiro TE, Büller HR, et al. Predicting the risk of venous thromboembolism in patients hospitalized with heart failure. Circulation. 2014;130:410–418. doi:10.1161/circulationaha.113.003126
   PubMed Web of Science ®Google Scholar
• Wu ZQ, Li KX, Zhu Q, et al. Application value of D-dimer testing and Caprini risk assessment model (RAM) to predict venous thromboembolism (VTE) in Chinese non-oncological urological inpatients: a retrospective study from a tertiary hospital. Transl Androl Urol. 2020;9:1904–1911. doi:10.21037/tau-20-320
   PubMed Web of Science ®Google Scholar
• Han D. Impact of D-Dimer for Prediction of Incident Occult Cancer in Patients with Unprovoked Venous Thromboembolism. PLoS One. 2016;11:e0153514. doi:10.1371/journal.pone.0153514
   PubMed Web of Science ®Google Scholar
• García-Cervera C, Giner-Galvañ V, Wikman-Jorgensen P, et al. Estimation of admission D-dimer cut-off value to predict venous thrombotic events in hospitalized covid-19 patients: analysis of the SEMI-COVID-19 Registry. J Gen Intern Med. 2021:1–9. doi:10.1007/s11606-021-07017-8
   Web of Science ®Google Scholar
• Hu W, Xu D, Li J, et al. The predictive value of D-dimer test for venous thromboembolism during puerperium in women age 35 or older: a prospective cohort study. Thromb J. 2020;18:26. doi:10.1186/s12959-020-00241-y
   PubMed Web of Science ®Google Scholar
• Schünemann HJ, Cushman M, Burnett AE, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv. 2018;2:3198–3225. doi:10.1182/bloodadvances.2018022954
   PubMed Web of Science ®Google Scholar
• Greene MT, Spyropoulos AC, Chopra V, et al. Validation of risk assessment models of venous thromboembolism in hospitalized medical patients. Am J Med. 2016;129:1009–1001.e1018. doi:10.1016/j.amjmed.2016.03.031
   Web of Science ®Google Scholar
• Nendaz M, Spirk D, Kucher N, et al. Multicentre validation of the Geneva Risk Score for hospitalised medical patients at risk of venous thromboembolism. Explicit ASsessment of Thromboembolic RIsk and Prophylaxis for Medical PATients in Switzerland (ESTIMATE). Thromb Haemost. 2014;111:531–538. doi:10.1160/th13-05-0427
   PubMed Web of Science ®Google Scholar
• Flanders SA, Greene MT, Grant P, et al. Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism: a cohort study. JAMA Intern Med. 2014;174:1577–1584. doi:10.1001/jamainternmed.2014.3384
   PubMed Web of Science ®Google Scholar
• Gunen H, Gulbas G, In E, et al. Venous thromboemboli and exacerbations of COPD. Eur Respir J. 2010;35:1243–1248. doi:10.1183/09031936.00120909
   PubMed Web of Science ®Google Scholar
• Meitei SP, Tale S, Negi AK, et al. Prevalence and characteristics of venous thromboembolism in severe exacerbation of chronic obstructive pulmonary disease in a tertiary care hospital in India. Monaldi Arch Chest Dis. 2021. doi:10.4081/monaldi.2021.1742
   PubMed Web of Science ®Google Scholar
• Zhai Z, Kan Q, Li W, et al. VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients: the Identification of Chinese Hospitalized Patients’ Risk Profile for Venous Thromboembolism (DissolVE-2)-A Cross-sectional Study. Chest. 2019;155:114–122. doi:10.1016/j.chest.2018.09.020
   PubMed Web of Science ®Google Scholar
• Lederle FA, Zylla D, MacDonald R, et al. Venous thromboembolism prophylaxis in hospitalized medical patients and those with stroke: a background review for an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2011;155:602–615. doi:10.7326/0003-4819-155-9-201111010-00008
   PubMed Web of Science ®Google Scholar
• Grant PJ, Greene MT, Chopra V, et al. Assessing the Caprini score for risk assessment of venous thromboembolism in hospitalized medical patients. Am J Med. 2016;129:528–535. doi:10.1016/j.amjmed.2015.10.027
   PubMed Web of Science ®Google Scholar
• Rothberg MB, Lindenauer PK, Lahti M, et al. Risk factor model to predict venous thromboembolism in hospitalized medical patients. J Hosp Med. 2011;6:202–209. doi:10.1002/jhm.888
   PubMed Web of Science ®Google Scholar
• Zhou H, Hu Y, Li X, et al. Assessment of the risk of venous thromboembolism in medical inpatients using the Padua Prediction Score and Caprini Risk Assessment Model. J Atheroscler Thromb. 2018;25:1091–1104. doi:10.5551/jat.43653
   PubMed Web of Science ®Google Scholar
• Vardi M, Ghanem-Zoubi NO, Zidan R, et al. Venous thromboembolism and the utility of the Padua Prediction Score in patients with sepsis admitted to internal medicine departments. J Thromb Haemost. 2013;11:467–473. doi:10.1111/jth.12108
   PubMed Web of Science ®Google Scholar
• Depietri L, Marietta M, Scarlini S, et al. Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a ”real life” prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study). Intern Emerg Med. 2018;13:527–534. doi:10.1007/s11739-018-1808-z
   PubMed Web of Science ®Google Scholar
• Jara-Palomares L, Solier-Lopez A, Elias-Hernandez T, et al. D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis. Br J Cancer. 2018;119:915–921. doi:10.1038/s41416-018-0269-5
   PubMed Web of Science ®Google Scholar
• Husebø GR, Gabazza EC, D’Alessandro Gabazza C, et al. Coagulation markers as predictors for clinical events in COPD. Respirology. 2021;26:342–351. doi:10.1111/resp.13971
   PubMed Web of Science ®Google Scholar
• Polosa R, Malerba M, Cacciola RR, et al. Effect of acute exacerbations on circulating endothelial, clotting and fibrinolytic markers in COPD patients. Intern Emerg Med. 2013;8:567–574. doi:10.1007/s11739-011-0636-1
   PubMed Web of Science ®Google Scholar
• Shi J, Ye J, Zhuang X, et al. Application value of Caprini risk assessment model and elevated tumor-specific D-dimer level in predicting postoperative venous thromboembolism for patients undergoing surgery of gynecologic malignancies. J Obstet Gynaecol Res. 2019;45:657–664. doi:10.1111/jog.13832
   PubMed Web of Science ®Google Scholar
• Gibson CM, Spyropoulos AC, Cohen AT, et al. The IMPROVEDD VTE risk score: incorporation of D-dimer into the IMPROVE score to improve venous thromboembolism risk stratification. TH Open. 2017;1:e56–e65. doi:10.1055/s-0037-1603929
   PubMedGoogle Scholar